Cargando…
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
In IDH-mutant astrocytoma, IDH2 mutation is quite rare and biological mechanisms underlying tumor progression in IDH2-mutant astrocytoma remain elusive. Here, we report a unique case of IDH2 mutant astrocytoma, CNS WHO grade 3 that developed tumor progression. We performed a comprehensive genomic an...
Autores principales: | Tateishi, Kensuke, Miyake, Yohei, Nakamura, Taishi, Iwashita, Hiromichi, Hayashi, Takahiro, Oshima, Akito, Honma, Hirokuni, Hayashi, Hiroaki, Sugino, Kyoka, Kato, Miyui, Satomi, Kaishi, Fujii, Satoshi, Komori, Takashi, Yamamoto, Tetsuya, Cahill, Daniel P., Wakimoto, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680361/ https://www.ncbi.nlm.nih.gov/pubmed/38012788 http://dx.doi.org/10.1186/s40478-023-01683-x |
Ejemplares similares
-
ET-1 Translational research platform for malignant brain tumors
por: Tateishi, Kensuke, et al.
Publicado: (2021) -
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient
por: Negri, T, et al.
Publicado: (2007) -
ET-8 Integrated diagnostic approach to predict prognosis for malignant gliomas
por: Isoda, Masataka, et al.
Publicado: (2021) -
MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
por: Yanagisawa, Shunsuke, et al.
Publicado: (2021) -
GEN-8 Real-time PCR based intraoperative genetic analysis for gliomas
por: Takabayashi, Katsuhiro, et al.
Publicado: (2021)